Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
After receiving clearance from the U.S. Food and Drug Administration for its medical device, Houston-based Arcos Inc. is launching into discussions with providers and plans to ramp up manufacturing. The device is aimed at treating severely burned patients. After a person is burned, fluid intake is critical, Arcos CEO Chris Meador said. However, too much or too little fluid can lead to major complications.Meador’s company, with $770,000 in funding from the U.S. Army, developed a device that provides specific recommendations to treat individual patients every hour throughout the critical fluid-intake phase. The company plans to market the device to the Army as well as civilian-burn intensive care units. Arcos is currently in talks with local providers that take care of burn victims, but Meador declined to name names.
Help employers find you! Check out all the jobs and post your resume.
